Tracey Bryant, PA
Physician Assistant · Kennewick, WANPI 1962473256
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 276 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 276 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$979
- AstraZeneca$973
- Pfizer$475
- Boehringer Ingelheim$473
- Novo Nordisk$418
- Sanofi Pasteur Inc.$208
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,153100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $979 |
| AstraZeneca | 45 | $973 |
| Pfizer | 31 | $475 |
| Boehringer Ingelheim | 24 | $473 |
| Novo Nordisk | 25 | $418 |
| Sanofi Pasteur Inc. | 8 | $208 |
| Lilly USA, LLC | 11 | $190 |
| GSK | 8 | $189 |
| Exact Sciences | 5 | $119 |
| Novartis | 5 | $102 |
| Exeltis, USA Inc. | 6 | $99 |
| Astellas Pharma US Inc | 4 | $88 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $65 |
| Bayer | 4 | $59 |
| Alk-abello, Inc | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Mylan Specialty L.p. | 3 | $50 |
| Abbott | 2 | $47 |
| Organon | 7 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $38 |
| Coopersurgical, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $36 |
| Merck | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $24 |
| Shield Therapeutics Inc | 1 | $22 |
| Mylan Inc. | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Sage Therapeutics, LLC | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Optumhealth Care Solutions, LLC | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$5,153 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 14 | $12,600 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $295 |
| Bupropion XlBupropion Hcl | 14 | $288 |
| Levothyroxine Sodium | 32 | $282 |
| Omeprazole | 14 | $234 |
| Hydromorphone Hcl | 12 | $168 |
| Tramadol Hcl | 24 | $150 |
| Oxycodone Hcl | 12 | $147 |
| Simvastatin | 11 | $139 |
| Lisinopril | 12 | $126 |
| Hydroxyzine Hcl | 12 | $110 |
| Trazodone Hcl | 30 | $102 |
| Sertraline Hcl | 12 | $97 |
| Metoprolol Succinate | 12 | $87 |
| Rosuvastatin Calcium | 16 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $418 | $12,60014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,741 physician assistant providers in Washington.
Other physician assistant in Kennewick
- Kellie DuarteKennewick$11K
- Calista ComstockKennewick$7K
- Jill KandoraShoreline$437K
- Jeannette HartRichland$263K
- Lance KeckTacoma$162K
- Erinn KingSeattle$129K
- Christy VathSeattle$75K
- Scott TaylorMercer Island$71K
- Gina FragioneGraham$69K
- Regan BrownSpokane$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.